71 results
424B5
CNTA
Centessa Pharmaceuticals plc
13 Sep 24
Prospectus supplement for primary offering
4:02pm
and Wales
Delaware
Stockholder Litigation
Under the laws of England and Wales, generally, the company, rather than its shareholders, is the proper claimant
8-K
CNTA
Centessa Pharmaceuticals plc
13 Sep 24
Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares
4:00pm
-looking statements contained in Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995 Any
424B5
CNTA
Centessa Pharmaceuticals plc
11 Sep 24
Prospectus supplement for primary offering
4:40pm
Stockholder Litigation
Under the laws of England and Wales, generally, the company, rather than its shareholders, is the proper claimant in an action in respect
S-3ASR
CNTA
Centessa Pharmaceuticals plc
11 Sep 24
Automatic shelf registration
4:01pm
to the shareholders.
England and Wales
Delaware
Stockholder Litigation
Under the laws of England and Wales, generally, the company, rather than its shareholders
8-K
EX-99.2
CNTA
Centessa Pharmaceuticals plc
10 Sep 24
Regulation FD Disclosure
7:08am
Securities Litigation Reform Act of 1995. Statements in this presentation that which speak only as of the date this presentation is given. All
DEFA14A
nfq27k woqi0rr
20 May 24
Additional proxy soliciting materials
8:48pm
424B5
dorvl
24 Apr 24
Prospectus supplement for primary offering
8:53pm
8-K
xcputvq zj
24 Apr 24
Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
9:26am
424B5
vo583dmozsj8opk9kzy
23 Apr 24
Prospectus supplement for primary offering
5:16pm
8-K
EX-99.2
z5atu
22 Apr 24
Regulation FD Disclosure
7:15am
8-K
EX-99.1
751cb1m9ftwn
9 Feb 24
Regulation FD Disclosure
7:12am
8-K
EX-99.1
7k5w zv272i
9 Jan 24
Regulation FD Disclosure
7:56am